Solid Q4e ahead, likely to end '24e with a fifth guidance upgrade Market conditions appear unchanged...
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) offentliggjorde den 31 december...
Redeye leaves a comment on Xbrane’s press release stating that it now has re-submitted its Lucentis ...
Redeye adjusts its estimates after Institut Bergonié terminated the collaboration agreement to explo...
The Board of PMD Device Solutions has filed for bankruptcy following extensive reviews of the compa...
IT market weakness hitting Proact After showing good resilience so far this year, Proact had to prof...
Nettoomsättningen uppgick till 53,1 MSEK (50,0) i det andra kvartalet (aug-okt) i Purefuns brutna rä...
Redeye comments on Maximum Entertainment’s divestment of certain assets within Merge Games which wil...
Redeye updates its estimates and fair value range following Ngenic’s share issue announcement and Q3...
Gapwaves entered a product sales agreement with Smartmicro worth SEK90m, with an expected ramp-up st...
Neovici AB (”Neovici” eller Bolaget” )meddelade den 20 december att bolaget har ingått avtal avseend...
Redeye comments briefly on Evolution’s press release regarding a review initiated by UKGC due to Evo...
On December 20, 2024, the Swedish Inspectorate of Strategic Products (ISP) concluded its review of X...
Redeye comments on Gasporox’s convertible debt financing.
Bolaget börjar gradvis få en stabilare tillväxt och jobbar mer intensivt med distributörerna i syfte...
Imflifidase shows robust efficacy results in phase 2 among patients with severe GBS.
Redeye is encouraged by Sivers Semiconductors’ announcement of a strengthened partnership framework ...
Avtech has secured its second-largest contract, signing an agreement with LATAM Airlines valued at E...
Redeye gives a brief comment on FMG’s downward revision of its full-year guidance.
Redeye comments on Surgical Science announcing an opportunistic bolt-on deal by offering to acquire ...
